Articoli con mandati relativi all'accesso pubblico - Simon ManningUlteriori informazioni
Disponibili pubblicamente: 6
NMDA receptor blockade with memantine attenuates white matter injury in a rat model of periventricular leukomalacia
SM Manning, DM Talos, C Zhou, DB Selip, HK Park, CJ Park, JJ Volpe, ...
Journal of Neuroscience 28 (26), 6670-6678, 2008
Mandati: US National Institutes of Health
Bumetanide enhances phenobarbital efficacy in a rat model of hypoxic neonatal seizures
RT Cleary, H Sun, T Huynh, SM Manning, Y Li, A Rotenberg, DM Talos, ...
PloS one 8 (3), e57148, 2013
Mandati: US National Institutes of Health
Neuroprotective agents for neonatal hypoxic–ischemic brain injury
Q Wu, W Chen, B Sinha, Y Tu, S Manning, N Thomas, S Zhou, H Jiang, ...
Drug Discovery Today 20 (11), 1372-1381, 2015
Mandati: Bill & Melinda Gates Foundation
Protection of melatonin in experimental models of newborn hypoxic‐ischemic brain injury through MT 1 receptor
B Sinha, Q Wu, W Li, Y Tu, AC Sirianni, Y Chen, J Jiang, X Zhang, ...
Journal of pineal research 64 (1), e12443, 2018
Mandati: Bill & Melinda Gates Foundation, US National Institutes of Health, National …
Minocycline treatment following hypoxic/ischaemic injury attenuates white matter injury in a rodent model of periventricular leucomalacia
M Lechpammer, SM Manning, F Samonte, J Nelligan, E Sabo, DM Talos, ...
Neuropathology and applied neurobiology 34 (4), 379-393, 2008
Mandati: US National Institutes of Health
The clinically available NMDA receptor antagonist, memantine, exhibits relative safety in the developing rat brain
SM Manning, G Boll, E Fitzgerald, DB Selip, JJ Volpe, FE Jensen
International Journal of Developmental Neuroscience 29 (7), 767-773, 2011
Mandati: US National Institutes of Health
Le informazioni sulla pubblicazione e sul finanziamento vengono stabilite automaticamente da un software